How Peripheral Nerves Recover — An Introduction to Nerve Regeneration

Imagine someone who has deeply cut their wrist with a knife. At first, the sensation in their thumb and index finger disappears and strength does not go into their fingers. If they surgically reconnect the severed nerves and wait several months, sensation gradually returns toward the fingertips and strength begins to return to the muscles as well. Even if it is not completely like before, they come to use the lost hand again to some extent.

This kind of recovery is possible because the nerves extending to the limbs actually grow back again if conditions are right, even when they are cut. The long nerve bundles of the brain and spinal cord that are severed in stroke or spinal cord injury cannot grow back as they originally were. The primer article "Paralysis and Spasticity — Where the Command Breaks Shapes What Follows" looked at how lower motor neurons—that is, the nerve cells that bring commands directly from the spinal cord to the muscle—pass through inside the peripheral nerves, and when cut, grow back along the tube. This article covers what comes next: Walleration degeneration, Schwann cells, axon regeneration, reinnervation, and miswiring, which appear repeatedly in rehabilitation medicine and hand surgery papers.

These two articles are a pair. The brain and spinal cord side is covered by "How the Central Nervous System Recovers — A Primer on Neuroplasticity" in the same series, and the neuroplasticity that that recovery relies on is the ability of the brain to reorganize itself while building new neural connections (the primer "Neuroplasticity — A Brain That Builds New Roads Beside the Broken Ones").

Why You Need to Know — It Regrows, But Not Completely

Peripheral nerve injuries are not rare. In a 10-year investigation of 5,777 polytrauma patients at a Level 1 trauma center, 2.8% had injured a peripheral nerve in a limb. Traffic accidents accounted for 46% of the causes, and 54% required surgery (PMID 9680023). The injury leads to loss of sensation, reduced muscle strength, and chronic neuropathic pain caused by the nerve itself, wearing away daily life and working ability for a long time (PMID 41634808).

The point where it diverges from the recovery of the brain and spinal cord is right here. If stroke rehabilitation is the work of reorganizing surviving brain tissue, the recovery of peripheral nerve injury is above all the work of actually making cut nerve fibers grow anew. An axon is a branch stretching long from the body of a nerve cell, a wire that carries signals all the way to its end. It is also called a nerve fiber. Unlike the nerves of the brain and spinal cord, injured peripheral nerves have the ability to make axons grow back and take charge again of target organs like muscles or skin that they originally took charge of (PMID 33212795). This intrinsic regenerative ability definitely exists. However, that ability is limited, so cases where sensation and movement return completely are still rare (PMID 32602098, PMID 40332790).

Peripheral nerves regrow, but they do not return completely. This tension is the center of the peripheral nerve recovery story. What most rehabilitation papers ask is also ultimately one thing: what makes this regeneration faster, more precise, and more complete.

The Big Picture — The PNS Regenerates, The CNS Relies on Plasticity

The nervous system is broadly divided into two. The central nervous system (CNS) is the brain and spinal cord. The peripheral nervous system (PNS) is the nerves that branch out from the brain and spinal cord to the limbs, skin, and organs. The principles of nervous system recovery differ fundamentally depending on the injured site, and blurring this distinction leads to misunderstanding nerve recovery as a whole.

Peripheral nerves grow back. After an injury, the peripheral nervous system creates a permissive environment that encourages regeneration—surrounding conditions that support rather than block growing axons—and turns on the intrinsic growth capacity of neurons (nerve cells). Thus, axons spontaneously grow back out again (PMID 17341159). One more thing is needed for function to return. Myelin is a membrane wrapped in multiple layers around an axon, helping signals pass through quickly. Schwann cells are supporting cells in the peripheral nervous system that wrap around axons to form myelin. Functional recovery happens when remyelination occurs, with Schwann cells wrapping around the regrown axon once more (PMID 17341159). Neurons of mature peripheral nerves can robustly regenerate axons over long distances (PMID 29989351).

The long nerve bundles of the brain and spinal cord do not grow back like this. Injured axons in the mature mammalian central nervous system rarely regenerate (PMID 23896200). Spinal cord injury practically does not lead to regrowth (PMID 10416756). The reasons are twofold. The central nervous system contains many inhibitory molecules that block growth (extrinsic factors), and the intrinsic growth capacity of the neurons themselves is also weak (PMID 29989351). Wallerian degeneration (covered in ②)—which breaks down and clears away nerve fibers below the injury site—also occurs much more slowly in the central nervous system, and this delay plays a part in the failure of regeneration (PMID 28553320).

Thus, the recovery of the two worlds diverges. Recovery after stroke or spinal cord injury relies more on reorganizing and strengthening surviving circuits than on newly reconnecting severed axons. Recovery from peripheral nerve injury relies heavily on actually making axons grow back and reconnect to their targets. Recovery in the brain and spinal cord relies mainly on neuroplasticity, while recovery in peripheral nerves relies on regeneration.

Easy Core Concepts — How Regeneration Happens

Peripheral nerve regeneration is a process where multiple stages interlock and run in sequence. We look in turn at starting from the depth of the injury, clearing debris, paving the path, and axon growth and reconnection, and finally look at two traps that ruin regeneration: miswiring and time.

① The Grades of Injury — The Same "Nerve Injury" Has Different Depths

The severity of "injuring a nerve" varies widely. The two classic classifications that divide this are the Seddon classification and the Sunderland classification (PMID 42376266, PMID 35738957).

The Seddon classification has three grades. The lightest, neurapraxia, is a state where the axon is fine and only signal transmission is blocked at one spot. This condition where the axon remains connected but signals cannot cross that segment is called conduction block. Axonotmesis is a state where the axon is severed, but the connective tissue skeleton and Schwann cell tubes wrapping it are relatively intact. It is common in traction injuries where a nerve is pulled during a fall or a car accident. The most severe, neurotmesis, is a state where the nerve trunk and connective tissue structures are completely broken, as in cases of a complete cut or severe crushing (PMID 42376266). The Sunderland classification divides this framework into more detailed grades (PMID 42376266, PMID 35738957).

Grades matter because they tell us whether a path remains for the growing axon to follow. Each individual axon inside a peripheral nerve passes through a thin connective tissue tunnel called the endoneurial tube, and Schwann cells that have lost their nerve line up along this tube to guide and support the regenerating axon (PMID 33212795). This tube lined up with Schwann cells is called a Schwann cell tube. When the Schwann cell tube is intact, the prognosis is good; when this path collapses, the growing axon loses the path to follow and the prognosis is bad. How each grade progresses over time is organized within the Seddon-Sunderland framework (PMID 35738957). A grade is essentially a map of "how much one can recover on their own."

Recovery on the lightest end of the axis sometimes happens without axons growing anew, as the blocked conduction is simply lifted. In a study following patients with ulnar neuropathy (a nerve going toward the pinky finger) who had their ulnar nerve compressed at the elbow for years, recovery was mainly explained by the resolution of conduction block and collateral reinnervation, with the contribution of actual axonal regeneration being minimal. Collateral reinnervation is when a surviving neighboring axon sprouts a collateral branch to take over muscle fibers that have lost their nerve. The authors added that the vast majority of lost axons in chronic focal neuropathy caused by prolonged compression at a single site will likely never recover (PMID 37373601).

Recently, an even lighter category that does not fit into any existing classification has been proposed. Sunderland zero is a reversible ischemic conduction block caused by a lack of blood, without the myelin sheath being stripped or the axon being lost. When the compression is released, function returns immediately without waiting for axonal regeneration. The reporters consider recognizing this category itself to be clinically crucial because intervening at the right time can bring about immediate improvement (PMID 42376266).

② Wallerian Degeneration — Clearing the Debris Opens the Way

When an axon is severed, the axon and myelin sheath further toward the body's end than the injury site do not remain intact. The side closer to the body's end (toward the muscles and skin) than the injured spot is called the distal end. The axon and myelin sheath of the distal end disintegrate on their own in a set order (programmed axonal death). Wallerian degeneration is the process in which the axon and myelin sheath of the distal end successively collapse and are cleared away after the axon is severed (PMID 41061042). This process is an essential preparatory step that creates a permissive environment for regeneration (PMID 34380909). The breaking down must happen first so that there is room for a new axon to grow.

The collapsed debris is cleared away together by Schwann cells and macrophages. Macrophages are immune cells that eat up fragments and invaders. The two cooperate to eat away the debris of the axon and myelin sheath (PMID 39101651). In particular, macrophages flock in large numbers to the injury site to help remove the debris. In doing so, influenced by the environment of that spot, they shift into an anti-inflammatory (M2) phenotype that calms inflammation and supports axon regeneration (PMID 26419777). A phenotype refers to the traits a cell displays and the work it does.

In the peripheral nervous system, Wallerian degeneration occurs swiftly and quickly sets up the preconditions for regeneration, but in the central nervous system, it is much slower and instead blocks regeneration (PMID 28553320).

③ Schwann Cells and Bands of Büngner — Guides for Regenerating Axons

The real protagonist of peripheral nerve regeneration may be the Schwann cell rather than the axon. These cells, which normally wrap around axons to form myelin, change their phenotype when damage occurs, multiplying and migrating. They turn off genes related to myelin and turn on growth-related genes such as neurotrophic factors. Neurotrophic factors are proteins that help nerve cells survive and grow. The repair phenotype is the state where Schwann cells stop making myelin after an injury and switch to helping regeneration (PMID 33212795, PMID 36261692).

The transformed Schwann cells line up long tubes stretching from the injury site to the distal target. Bands of Büngner are tubes formed by elongated Schwann cells, serving as tunnels and guides for regenerating axons. The structured Schwann cells secrete surface molecules that guide the regenerating fibers (PMID 10219748). Thus, where a growing axon ultimately reaches depends heavily on which tube it enters from the injury point (PMID 39579958).

What determines the final destination is under debate. One interpretation holds that the Schwann cell tubes themselves possess an identity—such as motor or sensory—that regenerating axons recognize. Another view counters that the relative magnitude of trophic support provided by each nerve branch decides the outcome (PMID 17250570). The authors of this review side with the latter argument (PMID 17250570).

④ Axon Regeneration — Slow Progress at 1 to 3 mm a Day

When preparation is complete, new axons sprout from the axon stump attached to the cell body of the surviving neuron and extend outward (PMID 33212795). The problem is the speed. Axons grow at a very slow pace of roughly 1 to 3 mm a day (PMID 39347555). The reported figures vary slightly depending on the type of injury. Some literature notes 3 to 4 mm a day following a crush injury, and 2 to 3 mm after a nerve is completely severed (PMID 10219748). Since a nerve severed at the wrist must grow dozens of centimeters to reach the fingertip muscles, it takes several months. This slowness is the root of the "race against time" that will appear later.

⑤ Reinnervation — Function Returns Only When Reconnected

It is not enough for an axon simply to grow and reach its target. Reinnervation is the process where the grown axon actually reconnects to a muscle or sensory receptor, and function returns only when this is achieved. In the case of a motor nerve, the axon tip must reconnect to the motor endplate (the neuromuscular junction), a specialized junction on the muscle surface, for the muscle to contract again (PMID 33212795). Ultimately, the success or failure of regeneration is decided by the quantity and accuracy of this reconnection.

Looking at quantity, the amount of axons that grew back into the muscle and the recovered muscle strength showed a positive correlation. However, in this experiment observing 7 rats, only 13.4% of normal axons returned inside the muscle, yet maximum muscle strength recovered up to 56.7%. The authors considered this muscle strength recovery unsatisfactory, and attributed the cause to nerve regeneration that remained at a mild to moderate level (PMID 23207170). The quantity of reinnervation and function move in the same direction, but they are not simply proportional.

⑥ Miswiring — The Problem of Regrown Axons Reaching the Wrong Places

The most troublesome trap of regeneration appears right here. Miswiring is when regrown axons fail to return to their original pathways and connect to the wrong targets. This happens frequently (PMID 33212795). Motor axons that used to carry instructions to muscles end up reaching targets with different functions, such as sensory organs (PMID 39579958). Regeneration happens robustly, but it is not accurate. It is not completely random, and regenerating motor axons show a preference for returning to muscle branches over skin branches. However, that preference is incomplete (PMID 17250570).

The degree of miswiring varies depending on how the nerve is connected. In mouse experiments, when a severed nerve was bridged using an autograft (taking another nerve from the patient's own body to place in the leg) or a silicone conduit (a tube into which both ends are inserted), 42–54% of the muscles were innervated by axons from the wrong nerve bundles. With resorbable conduits that dissolve in the body, it was 26–38%. When connected by separating individual nerve bundles, the level of miswiring was reduced to the point where it was visible in only one out of six regenerated subjects. Yet this group, which had the highest accuracy, actually showed the least amount of recovery, and walking did not clearly recover in any group. The authors concluded that resorbable conduits are best in the "balance between quantity and accuracy" (PMID 12490012). This means high accuracy alone is not enough.

Miswiring is a primary barrier blocking functional recovery. In experiments, the degree of motor axon miswiring and axon loss showed a clear correlation with the final functional deficit (PMID 24282624). In the same experiments, functional recovery remained poor even after nerves regrew and reached the muscles. This means that simply having axons reach muscles does not guarantee recovery (PMID 24282624).

In clinical practice as well, miswiring manifests as actual symptoms. It is particularly problematic in nerves that innervate opposing muscles together (such as the facial, laryngeal, and ulnar nerves). Synkinesis is a re-innervation disorder where trying to move one muscle causes another to move along with it, such as the eye closing when trying to smile (PMID 20656551, PMID 502707). Therefore, the key to recovery does not end with making axons grow more. Getting the regrown axons to find their correct places is the real key. The diagnosis of this field is that increasing the accuracy of axon pathfinding is decisive for elevating clinical outcomes (PMID 39579958).

⑦ Time Dependence — The Window of Recovery Closes

The last and perhaps most important property of peripheral nerve regeneration is that it races against time. Because regeneration is slow, the distal nerve and muscle are left unattended for a long time before the axon reaches its target. In the meantime, the supporting structures that prop up recovery slowly collapse.

Three things deteriorate at the same time. First, the growth capacity of neurons that have lost their target drops as time goes on. This is called chronic axotomy. Second, the growth-supporting ability of Schwann cells waiting for the axon in the distal segment withers away. The state of losing connection with a nerve is called denervation, and this state of Schwann cells lasting a long time is called chronic Schwann nerve denervation. Third, the muscle that has lost its nerve wastes away. However, one review points to the first two as the basis for poor recovery, and notes that muscles wasted from losing their nerve for a long time still retain the ability to accept a nerve again (PMID 38203836). Recovery is limited as the atrophy of Schwann cells and muscles progresses during the long period of waiting for reinnervation (PMID 34794826). When denervation lasts a long time, Schwann cells even switch to a senescence phenotype, sometimes spewing out factors that suppress axon regeneration (PMID 37860842). On the muscle side as well, if the motor endplate is left unattended for a long time, it breaks down and its reinnervation capacity drops (PMID 23281061).

The most decisive of the three is chronic denervation of the distal nerve stump, meaning the nerve piece remaining below the cut site. When controlling the times of axotomy, Schwann cell denervation, and muscle denervation separately in rat experiments, the number of motor neurons that regained their targets decreased exponentially over time. Among these, chronic denervation of the distal nerve stump was pointed out as the core factor in the decline of regeneration, with muscle denervation also contributing (PMID 21471367, PMID 19927054). This means that while waiting a long time to reconnect the nerve, the downward pathway itself withers, reducing the axons that grow back in. One review bridging basic research and the clinic lists chronic Schwann cell denervation, chronic axotomy, and misdirection as the main causes of poor recovery in the clinic, summarizing muscle atrophy itself as a secondary factor (PMID 23531634).

There is a time window for recovery, and if you are late, that window closes. This is the basis for all clinical efforts in peripheral nerve injury to act "quickly and close to the target." However, the time window does not mean rushing into surgery for all injuries. Since some injuries recover on their own, judging whether recovery happens within a set period goes hand in hand. We will revisit this point in the pediatric case in "Common Misunderstandings."

How It Actually Appears — The Clinical Landscape

Treatment for peripheral nerve injury is largely divided into surgery to reconnect the severed path, and rehabilitation to aid regeneration and reteach function. This section describes what treatments exist and how they work. Which method suits whom is determined by the attending medical staff depending on the type and location of the injury.

Bridging — Suturing, Grafts, Conduits, and Transfers

When the cleanly cut ends of a nerve can be brought together without tension, direct repair (nerve suture) is the standard treatment (PMID 40332790). Suturing under tension hinders nerve healing and yields poor results, so tension-free repair is an absolute rule (PMID 39373740).

The problem arises when a portion of the nerve is lost, creating a gap. Something must then bridge that gap. For a long time, the standard was the autograft, which also appeared in the earlier experiment. This method involves taking a piece of the patient's own sensory nerve to build a bridge. Although functional outcomes are good, it comes at the cost of sensory loss at the donor site and an additional surgery (PMID 39373740, PMID 40332790). Therefore, processed allografts—namely, treated nerves obtained from donors—and hollow artificial conduits are used as alternatives.

For short gaps in small sensory nerves (under roughly 15 mm), many reports indicate that sensory recovery is similar among autografts, conduits, and allografts (PMID 42175977). In a meta-analysis pooling and recalculating multiple studies, the meaningful recovery rates of autografts and allografts were similar, whereas conduits were lower (PMID 36728885). Whether conduits perform as well as grafts in short gaps varies across reports.

There is also another approach. Nerve transfer is a surgery that reroutes branches of healthy adjacent nerves to restore lost function. This method is also becoming increasingly widespread (PMID 37453767, PMID 38697743).

Despite all these efforts, results are frequently disappointing. It is estimated that only about 10% of adults with nerve injuries recover normal function, and the primary reason is the misrouting seen earlier—that is, axons growing into functionally incorrect targets (PMID 39579958). On the other hand, looking at satisfactory recovery, a lower benchmark than 'normal', about half of patients who undergo surgical nerve repair achieve it (PMID 40548860, PMID 31954163). The two numbers diverge by an order of magnitude because the measuring sticks are different. Because the results of both direct repair and gap reconstruction are frequently disappointing, one review concludes that further research into the biology of nerve regeneration is needed to elevate the outcomes of all nerve repairs (PMID 42175977).

Helping Out — Brief Electrical Stimulation

Among the attempts to accelerate regeneration itself after surgery, the one with the strongest evidence is brief electrical stimulation (BES). Brief electrical stimulation is a method of applying electrical stimulation to the nerve near the injury site during surgery for exactly 1 hour, at a low frequency of 20 Hz. Then, the expression of regeneration-related genes increases in neurons, the machinery used for growth is transported more quickly to the front of the axon, and axon growth and target reinnervation are dramatically accelerated (PMID 38203836, PMID 39347555).

This effect, established in animals, has also been translated into human clinical trials. A randomized controlled trial in patients who underwent carpal tunnel syndrome (a condition where a nerve is compressed in a narrow passage in the wrist) surgery is the first case. A randomized controlled trial is a study that randomly divides participants into treatment and control groups to compare them. In this trial, the brief electrical stimulation group showed a significant increase in the motor unit number estimate (MUNE) and faster axon regeneration. A motor unit is a single motor neuron and the bundle of muscle fibers it controls, and MUNE is an estimated value of that number through electrical testing. However, functional indicators improved similarly in both groups. The paper title itself begins with "without effect on functional outcome" (PMID 19800329).

Even in patients with complete transection and suture of the digital sensory nerve of the finger, sensory recovery in the stimulation group was consistently superior to that in the control group, but the difference in disability scores was not statistically significant (PMID 25727139). In a randomized trial that applied intraoperative stimulation to the accessory nerve at risk of injury during cancer surgery to remove lymph nodes in the neck (neck dissection), shoulder function was better preserved 1 year later, but the remaining two indicators did not reach significance (PMID 29361981). The accessory nerve is the nerve going to the muscle that lifts the shoulder.

Human evidence so far is certain up to "regeneration becomes faster," while "function becomes better" is still half-open. There is one more clue. Electrical stimulation promotes axon regeneration while significantly increasing miswiring, whereas exercise does not. Fortunately, the resulting loss of neuromuscular specificity had a very small impact on final function. The same review notes that the effect of exercise itself is still less clear (PMID 26121368, PMID 21120925).

Reeducating — Rehabilitation and Sensory Retraining

If surgery and stimulation open the path and accelerate the pace, rehabilitation revives actual function upon it. A review outlining the principles of peripheral nerve injury rehabilitation lists the sequence as follows. Above all, pain is lowered to a tolerable level. Next, the area is protected from secondary complications arising from disuse and lack of movement (such as contractures where joints stiffen). After that, muscle strength, flexibility, sensory discrimination, and manual dexterity are raised. Sensory discrimination is the ability to figure out what has touched you and where. And starting all of this early sets the stage for optimal recovery (PMID 11878078). Especially after nerve transfer surgery, surface electromyography biofeedback (sEMG biofeedback), which shows the muscle's electrical signals and helps learn control, is promising. This is because it helps motor relearning to relearn movement to match the new wiring (PMID 42394298).

Exercise is also studied as a tool to aid regeneration. A systematic review gathering animal model studies concluded that proper exercise is beneficial for nerve regeneration and functional recovery, while pointing out that what kind of exercise is done and when can be as important as the exercise itself (PMID 38282091). Indeed, in mouse experiments, the results of muscle reinnervation varied greatly depending on the type of exercise (intensity, continuous versus intermittent) (PMID 36148308). This means that just any exercise does not help. Some methods, such as electrical muscle stimulation (EMS), still have weaker evidence compared to how commonly they are used. The assessment of a review examining this field is that more standard protocols and well-designed clinical trials are needed (PMID 42394298).

Common Misconceptions — Illusions Surrounding Peripheral Nerve Regeneration

Regeneration is a fascinating concept, making it easy to exaggerate. Here we correct five common thoughts.

① 「Peripheral nerves grow back anyway」. They do grow back. However, it is slow and incomplete. The rate of regeneration is only 1 to 3 mm per day, and in the meantime, the distal environment and target muscles gradually atrophy (PMID 39347555). Complete functional recovery remains rare (PMID 32602098), and it is estimated that only about 10% of adults who injure a nerve regain normal function (PMID 39579958). "Growing back" and "recovering fully" are entirely different things.

② 「Once it regenerates, recovery is complete」. Even if an axon grows back and reaches a target, if it is the wrong target, function does not return. Misdirection is a primary cause of permanent functional deficit even after successful target reinnervation (PMID 24282624, PMID 12490012). Furthermore, if the muscle has already atrophied for a long time, recovery is limited even if the nerve returns (PMID 34794826). The success or failure of regeneration is determined together by quantity as well as accuracy and timing.

③ 「The faster and the more it grows, the better」. That is not necessarily true. Neurotrophic factors are essential elements that properly push most regenerating axons toward the distal part, but at the same time, they strongly stimulate collateral branch formation and increase misdirection. This phenomenon where regenerating axons are held up in a place overflowing with growth factors and spread haphazardly is called the "candy store effect." Therefore, recent strategies are shifting away from blindly increasing growth factors toward targeting intracellular signals that suppress collateral branching and turn on only the program to extend long until the axon reaches the target (PMID 24083434, PMID 24140746). Good recovery is robust yet accurate regeneration, and merely lush regeneration is not good recovery.

④ 「Time does not matter, surgery can be done anytime」. This is the most dangerous misconception. There is a time window for recovery. As time passes, the supportive capacity of distal Schwann cells wanes, muscles and motor endplates break down, and the intrinsic growth capacity of neurons also declines (PMID 21471367, PMID 37860842, PMID 23281061). Yet, methods to gauge how deep the damage is and whether axons are growing back without opening the body are still lacking. Therefore, a "wait-and-see" decision can lead to delayed surgery and worsen recovery (PMID 21488817).

Age is also a variable. Peripheral nerve regeneration is known to be better in children than in adults. In a study of 48 children who injured a nerve following supracondylar fracture of the humerus (a break in the upper arm bone just above the elbow), 20 children whose recovery began within 6 months achieved good outcomes comparable to the surgical group without surgery, even though their initial deficits were severe. The authors therefore concluded that surgical indications in children must be judged very carefully (PMID 38508207). The time window means judging whether recovery will occur within a set period rather than meaning surgery should be done as fast as possible. Conversely, in the elderly, debris clearance tends to be slow, delaying regeneration (PMID 24336714, PMID 40817901). That does not mean older patients gain no benefit from reconstruction, as there are reports of meaningful functional improvement obtained through methods like nerve transfers (PMID 40817901).

⑤ 「Central nerves also regenerate the same way if given stimulation」. That is not true. As seen earlier, the recovery principles of the central nervous system and the peripheral nervous system are fundamentally different. Central nervous system axons in adult mammals rarely regenerate due to an inhibitory environment and weak intrinsic growth capacity (PMID 29989351, PMID 23896200), and recovery in the brain and spinal cord centers on neuroplasticity (How the Central Nervous System Recovers — A Primer on Neuroplasticity). Regeneration strategies that work in peripheral nerves cannot be directly transferred to the central nervous system.

To Go Deeper

To go further, the following directions are good starting points.

• Schwann cell biology: How Schwann cells are reprogrammed into a repair phenotype after injury (c-Jun, Sox2, etc.) is the heart of regeneration research (PMID 36261692, PMID 38729050). Attempts to transplant these cells as cell therapy are also active (PMID 35966198).
• Strategies to accelerate regeneration: Short electrical stimulation (PMID 38203836), exercise (PMID 26121368), and growth factors such as growth hormone and IGF-1 (PMID 26890510, PMID 34794826) each attempt to improve regeneration speed, muscle maintenance, and reinnervation.
• Engineering that bridges the gap: Nerve conduits and tissue engineering trying to go beyond autografts are rapidly developing by combining materials, structures, and biological factors (PMID 32602098, PMID 38213640).
• The boundary between the CNS and PNS: The fundamental question of why peripheral nerves regenerate while central nerves struggle to do so leads to research trying to understand and release the "brakes" of the CNS that suppress regeneration (Nogo, myelin inhibitory factors, proteoglycans, etc.) (PMID 37690690, PMID 37884489, PMID 28596106).
• Limits and unresolved issues: The fundamental challenge that it is difficult to quantify regeneration in humans, how to reduce miswiring, and how to revive withered muscles and faded Schwann cells are the frontline of this field right now (PMID 31831264, PMID 42033083).

Peripheral nerves offer optimism in that they break the conventional wisdom that "a severed nerve cannot be undone." This is because they actually grow back. However, that optimism is not infinite. Regeneration is slow, frequently loses its way, and races against time. Understanding both the power of regeneration and its limits is the primer for reading a single peripheral nerve recovery paper properly. The story on the other side—of the brain and spinal cord recovering through principles other than regeneration—is in "How the Central Nervous System Recover — A Primer on Neuroplasticity".

This article is for informational purposes only and does not substitute for diagnosis or treatment. The diagnosis, timing of surgery, and direction of rehabilitation for nerve injury must be discussed with the attending medical team.

Source Papers

Big Picture of Recovery (PNS Regeneration vs. CNS Plasticity)

• Peripheral nerve regeneration and muscle reinnervation (PMID 33212795)
• Innovations in peripheral nerve recovery and future directions (PMID 41634808)
• Peripheral nerve injury and regeneration revisited (PMID 42047941)
• Optimizing peripheral nerve regeneration — surgical, biomolecular, and regenerative strategies (PMID 40332790)
• Basics and current strategies for peripheral nerve repair and regeneration (PMID 32602098)
• Peripheral regeneration — why the CNS cannot regenerate while the PNS regenerates spontaneously (PMID 17341159)
• The virtuous cycle of axon growth — comparing PNS and CNS regenerative capacities (PMID 29989351)
• Concepts and molecular basis of axon regeneration after CNS injury (PMID 23896200)
• Why the central nervous system fails to regenerate after injury (PMID 10416756)
• Axon degeneration — Schwann cells (differences in Wallerian degeneration speed between PNS and CNS) (PMID 28553320)

Injury Grades and Conduction Block

• Sunderland degree 0 injury and nerve injury classification (Seddon and Sunderland) (PMID 42376266)
• Epidemiology of extremity peripheral nerve injuries in polytrauma patients (2.8%, traffic accidents 46%, surgery 54%) (PMID 9680023)
• Electrodiagnostic interpretation for nerve injury management (PMID 35738957)
• Recovery of ulnar neuropathy at the elbow — resolution of conduction block and collateral sprouting rather than regeneration (PMID 37373601)
• Overview of the pathophysiology of peripheral nerve injury (PMID 15174821)
• Neurophysiology — mechanisms of injury and recovery (PMID 23895713)

Wallerian Degeneration, Schwann Cells, and Büngner Bands

• Sarm1 and Wallerian degeneration (programmed axon death) (PMID 41061042)
• Wallerian degeneration and microtubule dynamics (permissive environment) (PMID 34380909)
• The role of macrophages in Wallerian degeneration and axon regeneration (PMID 26419777)
• microRNA-301a and Wallerian degeneration (clearance of Schwann cell and macrophage debris) (PMID 39101651)
• Transcriptional regulation of peripheral nerve regeneration (Schwann cell reprogramming) (PMID 36261692)
• Basics of nerve injury, axon degeneration, and regeneration (guidance by Büngner bands, regeneration speed by injury type) (PMID 10219748)
• Schwann cell regeneration mechanisms and cell therapy (PMID 38729050)

Axon Regeneration, Reinnervation, and Motor Endplates

• Promoting recovery with electrical stimulation — regeneration speed of 1 to 3 mm/day (PMID 39347555)
• Sternocleidomastoid reinnervation — correlation between muscle strength recovery and axon regeneration (PMID 23207170)
• Remodeling of the neuromuscular junction in target muscles after delayed nerve suture (PMID 37201862)
• MMP3 and preservation of denervated motor endplates (PMID 23281061)

Misdirection

• Motor axon misdirection, loss, and behavioral deficits (PMID 24282624)
• Specificity of motor nerve regeneration (selective reinnervation) (PMID 17250570)
• Selective motor reinnervation — only about 10% of adults recover normal function, caused by misdirection (PMID 39579958)
• Functional impact of misdirection after graft and conduit repair (PMID 12490012)
• Clinical outcomes of reinnervation failure following focal peripheral nerve lesions (PMID 20656551)
• Mechanisms of synkinesis (PMID 502707)

Time Dependence and Chronic Denervation

• Short electrical stimulation and recovery — chronic axotomy and denervation (PMID 38203836)
• Basics of reduced recovery after delayed repair (PMID 21471367)
• The role of chronic Schwann cell denervation (PMID 19927054)
• Aging and chronically denervated aging Schwann cells (PMID 37860842)
• IGF-1 and chronic denervation (PMID 34794826)
• Neurobiology of nerve injury, regeneration, and functional recovery (from bench to bedside) (PMID 23531634)

Clinical — Surgery, Grafts, Conduits, and Transfers

• Reconstruction of nerve defects (autografts, allografts, and conduits) (PMID 42175977)
• Meta-analysis of nerve defect repair (autografts, allografts, and conduits) (PMID 36728885)
• Peripheral nerve grafting (PMID 39373740)
• Challenges in nerve repair and reconstruction (PMID 37453767)
• Surgery for mononeuropathies (nerve and tendon transfers) (PMID 38697743)
• Bioengineering strategies for nerve regeneration and repair (PMID 21488817)
• Biophysical stimulation and functional scaffolds (~50% recovery rate) (PMID 40548860)
• Review of repair strategies for injured peripheral nerves (roughly half recover) (PMID 31954163)
• Age and peripheral nerve regeneration (PMID 40817901)
• Nerve injury following pediatric supracondylar humerus fractures (PMID 38508207)
• Motor axon regeneration in young and aged animals (debris clearance speed) (PMID 24336714)

Clinical — Brief Electrical Stimulation (BES) Clinical Trials

• Randomized trial of BES in carpal tunnel syndrome patients (PMID 19800329)
• Randomized trial of electrical stimulation to enhance sensory recovery (PMID 25727139)
• Randomized trial of accessory nerve BES for shoulder function (BEST SPIN) (PMID 29361981)
• Electrical stimulation, exercise, and regeneration (cues for misdirection) (PMID 26121368)
• Misdirection and functional recovery (selective electrical stimulation) (PMID 21120925)

Clinical — Rehabilitation, Exercise, and Retraining

• Rehabilitation of peripheral nerve injuries (PMID 11878078)
• Electrical modalities in peripheral nerve injury rehabilitation (such as sEMG) (PMID 42394298)
• Promoting regeneration through exercise (systematic review of animal models) (PMID 38282091)
• Exercise protocols and muscle reinnervation (PMID 36148308)

Growth Factors and Misdirection-Related Mechanisms

• Growth hormone and axon regeneration and muscle atrophy (PMID 26890510)
• The dual nature of growth factors and cytokines (misdirection and the "candy store" effect) (PMID 24083434)
• Regulated GDNF expression to avoid the "candy store" effect (PMID 24140746)

Going Deeper — Cell Therapy, CNS Inhibitory Factors, and Quantification

• Systematic review of Schwann cell therapy (PMID 35966198)
• Advances in nerve conduits (PMID 38213640)
• Nogo-A fragments and axon regeneration (CNS inhibitory factor) (PMID 37690690)
• SLRPs and the inhibition of CNS regeneration (PMID 37884489)
• Axon regeneration and proteoglycans (PMID 28596106)
• The challenge of quantifying regeneration in patients (PMID 31831264)
• Chronic denervated muscle atrophy and myoblast therapy (PMID 42033083)